RW
Rastetter William H
Director
BoardM
Insider track record
Board DirectorNot enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the complete record of transactions filed by Rastetter William H, Director. Insider active across 4 companies, notably Fate Therapeutics INC. Aggregated, 13 filings have been logged. Breakdown: 0 buy · 1 sell. Total volume traded: €1.9m. Activity tracked since 2 June 2021. The latest transaction was filed on 5 November 2025 (Levée d'options). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Rastetter William H
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations13 total
18,000 shares@ US$47.8917.7% of flowCommon StockSEC:0001205903-25-000005:0
44,264 sharesCommon StockSEC:0000950170-25-091036:0
2,869 shares0Common StockSEC:0000914475-25-000134:0
30,000 shares@ US$42.7632.4% of flowCommon StockSEC:0000914475-25-000103:0
62,500 shares0Common StockSEC:0000950170-25-061111:0
14,250 shares@ US$146.6954.4% of flowCommon StockSEC:0000914475-24-000197:0
20,000 shares@ US$12.986.7% of flowCommon StockSEC:0000914475-24-000006:0
7,625 shares@ US$12.712.5% of flowCommon StockSEC:0001209191-23-027095:0
1,610 shares@ US$12.710.5% of flowCommon StockSEC:0001209191-23-025273:0
8,650 shares0Common StockSEC:0001209191-22-036353:0
20,000 shares@ US$6.662.8% of flowCommon StockSEC:0001209191-22-023284:0
2,681 shares0Common StockSEC:0000899243-21-022086:0
182 sharesCommon StockSEC:0001127602-16-035501:0
About Rastetter William H
RASTETTER WILLIAM H is a Director at Neurocrine Biosciences INC, Regulus Therapeutics Inc., Fate Therapeutics INC and ILLUMINA INC. Across 13 filings in total, the 13 sampled filings cover the period from 2016-01-04 to 2025-11-06 and show EUR 0 of buys and EUR 1905025 of sells, with Levée d'options as the most frequent transaction nature.